Targeting HIF-1α could be a potential therapeutic strategy for overcoming resistance in cancer therapy, and a non-toxic flavonoid, namely, APG, frequently inhibits the activity of HIF-1α and has an anti-tumor effect in hypoxic environments [35,36,37,38]. Here, HIF1A is linked to cancer.